share_log

Athira Pharma Q1 2024 GAAP EPS $(0.69) Beats $(0.78) Estimate

Benzinga ·  May 15 16:40

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.78) by 11.54 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment